Astellas Venture Management LLC, a wholly-owned venture capital subsidiary of Astellas Pharma Inc., and LabCentral, a launchpad for early-stage life-sciences startups, have entered a collaboration on the “Future Innovator Prize” formerly known as the Astellas Golden Ticket Competition. The Future Innovator Prize offers entrepreneurial scientists or emerging biotech start-ups one-year use of LabCentral’s state-of-the-art lab facility in Cambridge, MA, as well as access to Astell...